Enter your login e-mail to the account
Search
Search parameters
Search results
- Apixaban has been available for the treatment of venous thromboembolic disease for more than two years
Prof. MUDr. Debora Karetová, CSc., Prof. MUDr. Jan Bultas, CSc.
(1/2018, Drugs & drug classes ) - Mnemotechnic tools in emergencies
doc. MUDr. Viliam Dobiáš, CSc.
(5/2013, Interdisciplinary consilium ) - Current trends in therapeutic approaches for venous thromboembolism in outpatient practice
MUDr. Beáta Beňová, MUDr. Marta Fričová, MUDr. Iveta Susztayová, MUDr. Adriana Kafková, MUDr. M. Surová
(6/2011, Review articles )
- Antiphospholipid syndrome: one of the causes of ischaemic stroke in young age
MUDr. Andrea Bártková
(5/2010, Review articles )
- Publikujeme v zahraničí
(6/2014, Information & comments )
- Chosen problems in management of DOACs from cardiologist point of view
doc. MUDr. Matej Samoš, PhD., MUDr. Tomáš Bolek, Ing. Ingrid Škorňová, PhD., MUDr. Lucia Stančiaková, PhD., Prof. MUDr. Ján Staško, PhD., prof. MUDr. Marián Mokáň, DrSc., FRCP Edin.
(1/2019, Main topic ) - Apixaban – a new oral anticoagulant
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková
(1/2014, Drugs & drug classes ) - The risk of venous thromboembolism in giant cell arteritis
prof. MUDr. Viera Štvrtinová, CSc., MUDr. Denisa Čelovská, PhD., MUDr. Janka Krahulcová
(3/2016, Original articles & Case reports ) - Dabigatran-etexilate (Pradaxa®) in prevention of strokes in patients with atrial fibrillation
MUDr. Petr Janský
(1/2013, Drugs & drug classes ) - Apixaban has been available for the treatment of venous thromboembolic disease for more than two years
Doc. MUDr. Debora Karetová, CSc., prof. MUDr. Jan Bultas, CSc.
(3-4/2017, Drugs & drug classes ) - Paradoxical embolism to coronary artery as a first manifestation of thromboembolic disease – case report
MUDr. Branislav Ivan, MUDr. Peter Koiš, MUDr. Pavel Vahala, PhD.
(1/2015, Original articles & Case reports ) - XXI. Slovenský angiologický kongres spojený so 6. kurzom Central European Vascular Forum
(S3/2013, Supplement )